Int J MS Care 7:148-151, 2005/2006. Jan 9 & 10, 2007 1 Clinical Stabilization of a MS Patient after Tonsillectomy presented by Michael C. Levin, MD Department.

Slides:



Advertisements
Similar presentations
A&P Signs & Symptoms Management of condition
Advertisements

Shafiepour,mohsen MD. Kerman university of medical sciences.
Electrodiagnosis in the management and treatment of cervical and lumbar spine disorders Jonathan S. Rutchik, MD, MPH NEUROLOGY, ENVIRONMENTAL AND OCCUPATIONAL.
Evidence-Based Management of the Acute Lumbar Spine.
Spinal Cord Stimulation for Painful Legs and Moving Toes Syndrome Marie-Pierre Fournier-Gosselin MD 1, Rosalind S Chuang MD 2, Anthony E Lang MD 2, Cristina.
Idara C.Eshiet. A 50 year old woman had a sudden onset of dizziness and vomiting. Her family noticed that her left eyelid appeared to be drooping.
Devic’s neuromyelitis optica: its distinctive features and treatment
Overview of Multiple Sclerosis  Valerie Robinson, D.O. 
Practical Management of MS in the Primary Care Office Setting Case Study 2.
Rituximab (RITUXAN) & Multiple Sclerosis
MULTIPLE SCLEROSIS Dr. Belal M. Hijji, RN. PhD February 27, 2012.
FREEDOMS II TRIAL.
Neurology Dr Chris Derry Consultant Neurologist
Multiple Sclerosis Abdulelah Nuqali Intern. DemyelinationCNSAquired Multiple Sclerosis Optic neuritis Acute Disseminated Encephalomyelitis Hereditary.
Daclizumab High-Yield Process in Relapsing-Remitting Multiple Sclerosis (SELECT): A Randomised, Double-blind, Placebo-controlled Trial Aaron E. Miller,
Multiple Sclerosis (Definition)  “Multiple Sclerosis is a progressive demyelination of neurons in the central nervous system (the Brain and the Spinal.
“I Think My 17 Month Old Baby’s Drunk” Daniel P. Davis, MD UCSD Emergency Medicine.
“My migraine always comes back” Presented by: Julio Pascual Neuroscience Area, Service of Neurology, University Hospital Central de Asturias and Ineuropa,
Common Cervical Spine Disorders -Diagnosis and Treatment
VONHIPPEL LINDAU DISEASE
Clinical Hx (Case 1) 22 year old male. Ejected from a vehicle during a high speed single vehicle rollover. Immediate complaints of chest and back pain.
Friends With MS.com Bringing you support and information for Multiple Sclerosis.
An Analysis of Monthly Surveillance 3T MRI in MS patients switched from long term natalizumab to teriflunomide in a controlled, prospective study K. Edwards,
Pediatric Neurology Use of Biologic and Chemotherapeutic Agents Pediatric Neurology Use of Biologic and Chemotherapeutic Agents.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
MedPix Medical Image Database COW - Case of the Week Case Contributor: Steven J Goldstein Affiliation: University of Kentucky.
Multiple Sclerosis Rohith M. Reddy. Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body’s immune system.
SPINAL NERVE ROOT COMPRESSION AND PERIPHERAL NERVE DISORDERS Group A – AHD Dr. Gary Greenberg.
V V TRIGEMINAL NEURALGIA MAY HERALD NEUROMYELITIS OPTICA SPECTRUM DISORDERS Gisele O. Lima, Natália C. Talim, Lívia E. C. Talim, Juliana M. S. S. Amaral,
Jason Chiang, MD, PhD & Clayton Wiley, MD, PhD University of Pittsburgh Medical Center Department of Pathology Division of Neuropathology.
© 2014 Direct One Communications, Inc. All rights reserved. 1 A New Era of Therapy in Multiple Sclerosis: Balancing the Options and Challenges Ahead Jennifer.
Salient Features: SUBJECTIVE
Sagittal FLAIR images - Stable nonenhancing hyperintensities within the pericallosal white matter and bilateral centrum semiovale, consistent with known.
Syringobulbia Mark R. Lee, MD, PhD Pediatric Neurosurgery
Adult Medical-Surgical Nursing Neurology Module: Multiple Sclerosis.
Practical Management of MS in the Primary Care Office Setting Case Study 1.
Cases Neuroscience. Case 4 A 45 year old woman with a history of hypertension experienced a brief "blackout". She had complained of severe headaches,
A 17-year-old girl with encephalomyelitis Teaching NeuroImages Neurology Resident and Fellow Section © 2015 American Academy of Neurology.
MS مولتیپل اسکلروزیس. Client with Multiple Sclerosis Description Chronic demyelinating disease of CNS associated with - abnormal immune response to environmental.
Clinical reasoning By Dr. Walid I. Wadi Jan,5 th 2010.
A 30-year male with cognitive decline and unsteady gait Teaching NeuroImages Neurology Resident and Fellow Section © 2013 American Academy of Neurology.
Short Case Presentation Dr. Sania Khalid. Background Young female developed quadriplegia over a year Bed-ridden for 2 months Loss of bowel and bladder.
Multiple Sclerosis (MS) a serious, chronic and debilitating disease What is MS? A disease of the brain and spinal cord.
Multiple sclerosis – late onset. Authors: Vitalie Vacaras Vitalie Vacaras Damian Popescu Damian Popescu Radu Antonescu Radu Antonescu Anca Simu Anca Simu.
POSTER TITLE: CLINICAL AND RADIOLOGICAL PROFILE, TREATMENT AND OUTCOME OF PEDIATRIC ACQUIRED DEMYELINATING DISORDERS OF CENTRAL NERVOUS SYSTEM PRESENTER.
Physical Exam as the Hallmark for Medical Diagnosis: A case of metastatic uterine sarcoma presenting with neurologic complaints Amelia Bowman, MSIV1;
Carrie M. Hersh, D.O., Robert Fox, M.D.
25 yo healthy male college student
OPTIC NEURITIS DR ADNAN.
A 26-y.o. woman with RRMS and eruption of plaques.
KCHC Neuropathology Jianying Zeng, MD Chandrakant Rao, MD
Copyright © 2005 American Medical Association. All rights reserved.
Clinical course after Rituximab
Ambreen Khalil MD, Homer Moutran MD, Cristina Corr PA, Fares Elias MD.
Tumefactive rebound of Multiple Sclerosis following cessation of Fingolimod   Sharfaraz Salam, Daniel Dunbar, Tim Lavin, Adrian Pace, Tatiana Mihalova.
Dr. Kevin J. Pacheco Weakness.
Multiple Sclerosis.
Figure 1 An example of individual prediction of response to interferon β-1a and natalizumab in moderately advanced, active multiple sclerosis. Six treatment.
Jennifer Koay, MD Assistant Professor Department of Radiology
Pinnacle Neurology Dr. Jerome Freeman.
Case Studies.
with headache and seizures
Figure Immune checkpoint inhibitor–induced encephalitis before and after treatment with natalizumab Immune checkpoint inhibitor–induced encephalitis before.
Figure 2 Clinical course and response to therapy in 6 Australian patients with HMGCR antibodies The clinical course, creatine kinase (CK) levels, Medical.
Figure 1 Relapse and rituximab historyThe figure shows rituximab (RTX) treatment history as well as relapse history for 100 days prior to the first RTX.
MS Relapse Management: Team Approaches Colleen Harris MN NP MSCN
CASE STUDIES.
Figure 1 MRIs (case 1)‏ MRIs (case 1) An enlarging T2 lesion in the cerebral white matter near the angular gyrus and a new lesion in the left middle cerebellar.
A 57-year-old woman with a 3-month history of bilateral lower extremity tingling and progressive lower extremity weakness. A 57-year-old woman with a 3-month.
Chronic CNS-IRIS without coinfection.
Presentation transcript:

Int J MS Care 7: , 2005/2006. Jan 9 & 10, Clinical Stabilization of a MS Patient after Tonsillectomy presented by Michael C. Levin, MD Department of Neurology Memphis VAMC Memphis, TN Terry Wren, RN January 9 & 10, 2007 VA MS Centers of Excellence

Int J MS Care 7: , 2005/2006. Jan 9 & 10, Michael C. Levin, MD Department of Neurology Memphis VAMC Memphis, TN Terry Wren, RN reports that he has no relationships with commercial organizations to disclose.

Int J MS Care 7: , 2005/2006. Jan 9 & 10, year old woman with RRMS referred for multiple relapses Relevant past neurological history 3 years earlier: –Paresthesias of lower extremities for 1 week 1 year later: –Symptoms recurred and ascended to thoracic area associated with change in gait –Upper respiratory infection (URI) 1 week prior to onset Neurological exam: –Lower extremity weakness –Subjective sensory level of T10 –No pathologic reflexes –Wide based, ataxic gait MRI of brain and spinal cord: –Cervical and thoracic cord MRI negative –Brain MRI shows multiple focal areas of increased signal intensity in corpus callosum and periventricular white matter CSF positive for oligoclonal bands Patient diagnosed with RRMS Patient treated with intravenous methylprednisolone 1000 mg/day for 5 days with prednisone taper Symptoms improved Patient started on interferon beta- 1a 30 mcg per week

Int J MS Care 7: , 2005/2006. Jan 9 & 10, year old woman with RRMS referred for multiple relapses Neurological history –Documented 5 relapses in previous 10 months – each treated with methylprednisolone –Concurrent with each relapse she had an upper respiratory infection (URI) and sore throat for which she occasionally received antibiotics At time of referral: –1 week of pain and paresthesias of the left side of the face, numbness of right lower extremity that ascended to include the thoracic area & bilateral burning feet –6 th relapse in 10 months = 7.2 per year Neurological exam: –End gaze nystagmus –Numbness of left face –Decreased pinprick sensation from T12 – L1 on the right –Hyper-reflexia of lower extremities Medical exam: enlarged inflamed tonsils Refused IV steroids, treated with methylprednisolone dosepak MRI showed several new lesions, some enhancing (Figure 1 A) MRI spinal cord negative ENT evaluation shows chronic tonsillitis

Int J MS Care 7: , 2005/2006. Jan 9 & 10, year old woman with RRMS referred for multiple relapses

Int J MS Care 7: , 2005/2006. Jan 9 & 10, year old woman with RRMS referred for multiple relapses Patient underwent tonsillectomy: –3 weeks later felt ‘better’ but developed left sided numbness. Treated with IV methylprednisolone Restarted on interferon beta-1a 9 weeks post-op: –Normal neurological examination 13 months post-op: –One relapse treated with oral steroids –MRI improved –Annualized relapse rate of 1.85

Int J MS Care 7: , 2005/2006. Jan 9 & 10, year old woman with RRMS referred for multiple relapses

Int J MS Care 7: , 2005/2006. Jan 9 & 10, year old woman with RRMS referred for multiple relapses - discussion Infections are associated with increased risk of relapse and sustained disability –‘At Risk Periods – ARP’: defined as 2 weeks before the onset of a viral infection until 5 weeks post- infection Sibley et al., Lancet 1985: –Relapse rate 3X during ARP vs. non-ARP Anderson et al., J Neurol 1993: –Increased relapse rate during ARPs –correlation between URIs and more severe relapses Panitch et al., Ann Neurol 1994: –Relapse rate during ARPs = 2.92/year vs per year during non-ARPs (p<0.001) Rapp et al., Am J Phys Med Rehab 1995: –Increased risk of relapse associated with bacterial infections in hospitalized MS patients –Neurological improvement following aggressive treatment of the infection Buljevac et al., Brain 2002: –Increased risk of relapse and sustained neurological disability associated with ARPs

Int J MS Care 7: , 2005/2006. Jan 9 & 10, year old woman with RRMS referred for multiple relapses - discussion In this study: –Patient’s relapses correlated with URIs –Diagnosed with pharyngo- tonsillitis –Before tonsillectomy: Annualized relapse rate of 7.2 –After tonsillectomy: Felt better Annualized relapse rate of 1.85 Improved brain MRI Tonsillectomy during childhood may be a risk factor for MS – now refuted (Poskanzer, Lancet, Broadly et al., Multiple Sclerosis 2000) Uncontrolled studies show that tonsillectomy may stabilize psoriasis – an immune disorder of skin (Wilson et al., Pediatr Dermatol, 2003) We could not find another study that showed stabilization of MS following tonsillectomy We suggest a thorough evaluation for infection in MS patients with multiple relapses We do not advocate use of routine tonsillectomy for MS